Lv5
820 积分 2025-07-15 加入
Chimeric antigen receptor macrophage (CAR-M) immunotherapy in autoimmune inflammatory rheumatic diseases
5天前
已完结
Resetting autoimmune disease with CAR cell therapies
7天前
已完结
Toward In Vivo CAR T Cell Therapy: Perfecting CAR and Lipid Nanoparticle Design
11天前
已完结
Linker-dependent modulation of anti-CD22 scFv antibody stability and avidity: Combined structural and experimental insights
14天前
已完结
Boosting prime editing with engineered non-canonical pegRNAs
16天前
已完结
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
24天前
已完结
CRISPR-based therapeutic genome editing for inherited blood disorders
24天前
已完结
Rational design of selective bispecific EPO-R/CD131 agonists
1个月前
已完结
A new age of precision gene therapy
1个月前
已完结
Nanobody-enhanced T cell cancer immunotherapy: Advancing precision medicine
1个月前
已完结
皖公网安备34019202002308
